Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

類似資料

• The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
  著者:: Fu-Tsai Chung, 等
  出版事項: (2015-01-01)
• The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
  著者:: Chung, Fu-Tsai, 等
  出版事項: (2015)
• ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations
  著者:: Wang, Zhijie, 等
  出版事項: (2015)
• Monitoring of cyclooxygenase-2 levels can predict EGFR mutations and the efficacy of EGFR-TKI in patients with lung adenocarcinoma
  著者:: Li, Huanhuan, 等
  出版事項: (2015)
• Association between EGFR exon 19 or exon 21 mutations and survival rates after first-line EGFR-TKI treatment in patients with non-small cell lung cancer
  著者:: Jiang, Haiying, 等
  出版事項: (2019)